Literature DB >> 12940542

Overview of the current status of genetically modified plants in Europe as compared to the USA.

Peter Brandt1.   

Abstract

Genetically modified crops have been tested in 1,726 experimental releases in the EU member states and in 7,815 experimental releases in the USA. The global commercial cultivation area of genetically modified crops is likely to reach 50 million hectares in 2001, however, the commercial production of genetically modified crops in the EU amounts to only a few thousand hectares and accounts for only some 0.03% of the world production. A significant gap exists between the more than fifty genetically modified crop species already permitted to be cultivated and to be placed on the market in the USA, Canada and other countries and the five genetically modified crop species permitted for the same use in the EU member states, which are still pending inclusion in the Common Catalogue of agricultural plant species. The further development of the "green gene technology" in the EU will be a matter of public acceptance and administrative legislation.

Mesh:

Year:  2003        PMID: 12940542     DOI: 10.1078/0176-1617-01031

Source DB:  PubMed          Journal:  J Plant Physiol        ISSN: 0176-1617            Impact factor:   3.549


  2 in total

Review 1.  Genetically modified plants and human health.

Authors:  Suzie Key; Julian K-C Ma; Pascal Mw Drake
Journal:  J R Soc Med       Date:  2008-06       Impact factor: 5.344

2.  ptxD gene in combination with phosphite serves as a highly effective selection system to generate transgenic cotton (Gossypium hirsutum L.).

Authors:  Devendra Pandeya; LeAnne M Campbell; Eugenia Nunes; Damar L Lopez-Arredondo; Madhusudhana R Janga; Luis Herrera-Estrella; Keerti S Rathore
Journal:  Plant Mol Biol       Date:  2017-10-14       Impact factor: 4.076

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.